The official GBM journey has a shape.
Diagnosis.
Surgery, if surgery is possible.
Pathology.
Radiation.
Temozolomide.
Scans.
Maybe Optune.
Maybe recurrence.
Maybe a clinical trial.
Maybe bevacizumab.
Maybe hospice.
That version is not wrong.
It is just too clean.
It makes the disease look like a sequence of clinical events, when the lived experience is much more fractured. Families do not move through GBM one phase at a time. They move through overlapping questions, half-understood terms, sudden symptoms, scan fear, treatment decisions, trial searches, caregiver exhaustion, and grief that starts long before anyone is ready to call it grief.
Over the past year, Ember has had a close view of that second journey.
In our first year, families created 4,028 de-identified GBM conversation threads across more than 50 countries, generating nearly 49,000 total messages between users and the Companion. The latest analysis-ready dataset includes 20,874 user messages. These are not survey responses. They are not prompts written for research. They are the questions people asked when something in their life required an answer, or at least some steadier footing.
That distinction matters.
A survey asks people what they remember needing.
A conversation shows what they needed in the moment.

Comments
Nothing yet. Say the first thing.
Sign in to join the conversation.